iSpecimen Inc. (NASDAQ:ISPC) Short Interest Update

iSpecimen Inc. (NASDAQ:ISPC) was the target of a large increase in short interest in the month of March. As of March 13th, there was short interest totaling 3,073,818 shares, an increase of 227.2% from the February 26th total of 939,560 shares. Based on an average daily volume of 31,293,206 shares, the days-to-cover ratio is presently 0.1 days. Currently, 35.8% of the shares of the stock are sold short.

Analyst Ratings Changes

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of iSpecimen in a research report on Thursday, January 22nd. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock has an average rating of “Sell”.

iSpecimen Trading Up 1.3%

Shares of ISPC traded up $0.00 during mid-day trading on Thursday, reaching $0.16. 1,474,596 shares of the stock traded hands, compared to its average volume of 8,060,889. The company has a market cap of $1.54 million, a price-to-earnings ratio of -0.02 and a beta of 1.87. iSpecimen has a 1 year low of $0.14 and a 1 year high of $3.18. The firm has a fifty day moving average price of $0.29 and a 200 day moving average price of $0.59.

Institutional Trading of iSpecimen

An institutional investor recently bought a new position in iSpecimen stock. Scientech Research LLC acquired a new position in shares of iSpecimen Inc. (NASDAQ:ISPC) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 29,488 shares of the company’s stock, valued at approximately $38,000. Scientech Research LLC owned approximately 0.30% of iSpecimen at the end of the most recent quarter. Institutional investors and hedge funds own 13.62% of the company’s stock.

About iSpecimen

iSpecimen, Inc (NASDAQ:ISPC) operates an online life sciences marketplace designed to connect researchers with human biological specimens and associated clinical data. The company’s platform streamlines the sourcing of biospecimens—such as plasma, serum, fresh and frozen tissue, saliva, urine and peripheral blood mononuclear cells (PBMCs)—by matching demand from pharmaceutical, biotechnology, diagnostic and academic organizations with supply from a wide network of clinical sites and biobanks.

Through its on-demand procurement model, iSpecimen provides customized specimen collection and fulfillment services that help accelerate research timelines and improve data quality.